Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo

Strains of human immunodeficiency virus type 1 differ in their abilities to infect and replicate in primary human macrophages. Chimeric clones were constructed from a provirus unable to infect macrophages (NLHX) and envelope sequences (V3 loop) of viruses derived without cultivation from brain (YU2 and w1-1c1) or spleen (w2-1b4) tissues. The substituted V3 loop sequences in each case were sufficient to confer upon NLHX the ability to infect macrophages. Furthermore, an envelope domain immediately N terminal to the V3 loop also was found to modulate the level of replication in macrophages. These results demonstrate that an envelope determinant derived directly from patients with AIDS confers HIV-1 tropism for macrophages.

[1]  M. Hammarskjöld,et al.  Regulation of human immunodeficiency virus env expression by the rev gene product , 1989, Journal of virology.

[2]  J. Clements,et al.  Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages , 1983, Infection and immunity.

[3]  D. Ho,et al.  High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. McGuire,et al.  Immunofluorescent localization of equine infectious anemia virus in tissue. , 1971, The American journal of pathology.

[5]  R. Redfield,et al.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. , 1986, Science.

[6]  C. Cheng‐Mayer,et al.  Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene , 1991, Nature.

[7]  J. Clements,et al.  Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. , 1982, The Journal of general virology.

[8]  R. Desrosiers,et al.  Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. , 1991, The American journal of pathology.

[9]  J. Goudsmit,et al.  Neutralization of HIV‐1: a paradox of humoral proportions , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  C. Kuiken,et al.  HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. , 1991, Virology.

[11]  R. Gallo,et al.  The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Goudsmit,et al.  Genomic diversity and antigenic variation of HIV‐1: links between pathogenesis, epidemiology and vaccine development , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  H. Gendelman,et al.  Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Gendelman,et al.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.

[15]  C. Wiley,et al.  Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. F. Smith,et al.  Human Retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences: I--II; III--V , 1993 .

[17]  J. Hoxie,et al.  Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins. , 1991, AIDS research and human retroviruses.

[18]  B. Cullen,et al.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.

[19]  David Looney,et al.  Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.

[20]  T. Schulz,et al.  The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? , 1991, AIDS research and human retroviruses.

[21]  Andreas Meyerhans,et al.  Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.

[22]  G. Shaw,et al.  Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.

[23]  J. Kappes,et al.  Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes , 1991, Journal of virology.

[24]  D. Ho,et al.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.

[25]  W. O'brien,et al.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain , 1990, Nature.

[26]  L. Jagodzinski,et al.  Complete nucleotide sequences of functional clones of the AIDS virus. , 1987, AIDS research and human retroviruses.

[27]  J. Bonifacino,et al.  Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. , 1991, Virology.

[28]  E K Ross,et al.  Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.

[29]  D. Markovitz,et al.  Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. , 1986, JAMA.

[30]  L. Epstein,et al.  Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. , 1986, JAMA.